Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 600 41 365.9 |
96 | EP file number | EAKZ | 05 00 1476.0 |
97 | EP publication number | EPN | 1552831 |
54 | Designation/title | TI | Verwendung von Riluzol zur Behandlung Multipler Sklerose |
51 | IPC main class | ICM (ICMV) | A61K 31/425 (2006.01) |
22 | DE application date | DAT | Jun 2, 2000 |
96 | EP application date | EAT | Jun 2, 2000 |
43 | Date of first publication | OT | Jul 13, 2005 |
| Date of publication of grant | PET | Jan 7, 2009 |
71/73 | Applicant/owner | INH | Vereniging voor Christelijk Wetenschappelijk Onderwijs, Amsterdam, NL |
72 | Inventor | IN | Polman, Chris, 2051 HE Overveen, NL |
74 | Representative | VTR | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
| Address for service | | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 99201788 Jun 4, 1999
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 174328 P Jan 4, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001552831 Searchable text:
EP000001552831 Original document:
EP000001552831B1 Searchable text:
EP000001552831B1 |
43 | Date of first publication | EVT | Jul 13, 2005 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 25, 2020 (Show all update days)(Hide all update days)- Mar 25, 2020; Feb 18, 2020; Jun 26, 2018; Jul 20, 2017; Jul 11, 2017; Jul 7, 2016; Jul 11, 2015; Apr 21, 2015; Jul 24, 2014; Jul 9, 2014; Jul 17, 2013; Jul 10, 2013; Jan 27, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|